FDA Medical devices recall ·

Atellica¿ CH ¿2-Microglobulin (B2M) - In vitro diagnostic use in the… recall

Recall number
Z-0599-2025
Date
(initiated October 21, 2024)
Company / brand
Siemens Healthcare Diagnostics, Inc.
511 Benedict Ave, Tarrytown, NY, United States
Category
Medical devices › Class II
Classification
Class II
Status
Ongoing
Units affected
11330 units
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Atellica¿ CH ¿2-Microglobulin (B2M) - In vitro diagnostic use in the quantitative determination of ¿2-microglobulin in human serum and plasma. Siemens Material Number (SMN): 11097635

Why was it recalled?

Potential for falsely depressed auto-diluted results for samples above the measuring interval of 18.00 mg/L, up to 30.00 mg/L, when using the Atellica CH ¿2-Microglobulin (B2M) reagent.

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

UDI-DI: 00630414595566 All in-date and future Atellica CH B2M reagent lots

Distribution

Worldwide distribution - US Nationwide and the countries of Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Czech Republic, Denmark, Ecuador, Egypt, Finland, France, Germany, Greece, Hungary, India, Iran, Israel, Italy, Ivory Coast, Japan, Jordan, Kuwait, Mexico, Morocco, Oman, P.R. China, Pakistan, Paraguay, Poland, Portugal, Saudi Arabia, Saudi Arabia, Serbia, Slovakia, South Africa, Spain, Switzerland, Thailand, Turkey, U.A.E., Uganda, United Kingdom, Uruguay, Uzbekistan, Vietnam, Zaire.

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (medical devices), recall Z-0599-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.